I enjoyed reading that and think it is a very good comparison. Now look at it this way - Baeta Corp is even limited as to what they can do (only smoking, weight loss, & pain management).
If MMR Global can meet it's guidance by or before the end of this year ($27.8M), we may be able to call Baeta Corp. a Mickey Mouse company IMO. We know at any given time we could sign another biotech data deal for another $10-$15M. There is obvious interest. We also know there is anti-cd20 that could be worth another $30M+. Besides that, our core products are being offered at "the right time". People want to digitize paper and convert to EMR's and MMR Global offers them a cheap and easy solution. They are not only doing this in the US, but it will be practically all over the world in a few years.
I would be reluctant to say this if I did not see any big companies associated with MMR Global like Chartis, UNIS, Celgene, Kodak, etc.
The fact is that this company will be a stock pick of the year once they start speeding up this ever slow healthcare market with PHRs and EMRs. I am still betting we see the beginning of this in 2011.